Effect of ulipristal acetate on gene expression profile in endometrial cells in culture and in vivo upon post-ovulatory administration in fertile women. (4th May 2022)
- Record Type:
- Journal Article
- Title:
- Effect of ulipristal acetate on gene expression profile in endometrial cells in culture and in vivo upon post-ovulatory administration in fertile women. (4th May 2022)
- Main Title:
- Effect of ulipristal acetate on gene expression profile in endometrial cells in culture and in vivo upon post-ovulatory administration in fertile women
- Authors:
- Jiménez Guerrero, Maripaz
Fava, Mariana
Baccaro, Luiz F.
Caille, Adriana M.
Cuasnicú, Patricia S.
Horcajadas, José A.
Cohen, Débora J.
Bahamondes, Luis
Cotán, David
Munuce, María José - Abstract:
- Abstract: Purpose: To analyse the effect of ulipristal acetate (UPA) as emergency contraception (EC) on the gene expression of human endometrial cell line (HEC-1A) and endometrium from fertile women treated with UPA after ovulation. Materials and methods: HEC-1A cells were treated with UPA, and endometrial tissue from four healthy women was collected in cycles before, during and 2 months after post-ovulation pill intake. Ovulation and luteal phase were monitored, and endometrial biopsies were obtained at day LH + 7 in each cycle. In all cases, we analysed the expression profile of 192 genes associated to endometrial receptivity. Results: We observed a significant change in total transcriptomic activity of UPA-treated HEC-1A cells compared to controls. In vivo, we also observed a trend to down-regulation of genes in the UPA-treated cycle that was partially restored in the post-treatment cycle. Altogether, our results supported a partially reversible effect of UPA in gene expression associated with uterine receptivity. Conclusions: When UPA was administered after ovulation, it seems to induce a down-regulation of the main genes involved in conditioning the endometrium for implantation. This effect is partially restored two months after pill intake. The action of UPA on the endometrium for users of EC should be further investigated.
- Is Part Of:
- European journal of contraception & reproductive health care. Volume 27:Number 3(2022)
- Journal:
- European journal of contraception & reproductive health care
- Issue:
- Volume 27:Number 3(2022)
- Issue Display:
- Volume 27, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 27
- Issue:
- 3
- Issue Sort Value:
- 2022-0027-0003-0000
- Page Start:
- 199
- Page End:
- 207
- Publication Date:
- 2022-05-04
- Subjects:
- Ulipristal acetate -- emergency contraception -- implantation -- gene expression -- endometrium
Contraception -- Periodicals
Reproductive health -- Periodicals
Generative organs, Female -- Periodicals
Contraception -- Periodicals
Reproductive Medicine -- Periodicals
613.9 - Journal URLs:
- http://informahealthcare.com/journal/ejc ↗
http://informahealthcare.com/loi/ejc/ ↗
http://www.tandf.co.uk/journals/titles/13625187.asp ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/13625187.2021.1975270 ↗
- Languages:
- English
- ISSNs:
- 1362-5187
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.728227
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21736.xml